Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-20-009125
Filing Date
2020-04-14
Accepted
2020-04-14 09:07:33
Documents
1
Period of Report
2020-04-14

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT ea120636-pre14a_immucellcorp.htm PRE 14A 244286
  Complete submission text file 0001213900-20-009125.txt   245265
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-12934 | Film No.: 20790172
SIC: 2835 In Vitro & In Vivo Diagnostic Substances